The Company 2018-04-26T10:49:42+00:00

Mission

Our mission is to advance life science for better human health with next generation protein sequencing.

About Us

Rapid Novor Inc is the world’s leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics, the team has developed the technology to directly sequence the antibody proteins without needs to access the cell line.

As a University of Waterloo spin-off, the company is building its technology portfolios based on the twenty years of scientific research and inventions from Dr. Bin Ma, co-founder and chief scientist. The company’s REmAb™ antibody protein sequencing service has allowed the accurate sequencing of any given antibody proteins routinely. The company’s WILD™ service is the first commercially available service that can accurately distinguish the isomeric Isoleucine and Leucine using mass spectrometry.

The Story

For over a decade people have had the impression that de novo peptide sequencing with MS/MS is slow. Dr. Ma, as a bioinformatician who worked on this problem for years, was deeply disturbed and wanted to make a change.  Starting from January 2015, Dr. Ma has devoted himself to a new de novo sequencing tool, Novor. The outcome of this dedication is rewarding: Novor achieved a speed of 300 spectra per second with a MacBook Pro laptop computer, with accuracy better than other available tools.

With an order of magnitude faster than any other software out there, and a speed surpassing all modern mass spectrometers in the market, the software may enable applications that are not possible in the past. Thus, Rapid Novor Inc was founded to make it happen.

The Team

Bin Ma, Ph.D.
Bin Ma, Ph.D.President and Co-founder
Dr. Ma has 15 years of experience in bioinformatics research and commercialization. He is a professor in Cheriton’s School of Computer Science at University of Waterloo. He was formerly a co-founder and a board member at Bioinformatics Solutions Inc., where he created the PEAKS software. He is passionate in developing innovative and easy-to-use bioinformatics software and making it widely accessible in both the private and public sectors.
Mingjie Xie, M.Sc., M.B.A.
Mingjie Xie, M.Sc., M.B.A.CEO and Co-founder
Mr. Xie has 10 years of experience developing and commercializing software solutions and technologies in the field of proteomics using mass spectrometry. Prior to co-founding Rapid Novor, he was the Chief Operating Officer at BSI and spent 5 years in several software companies in China. Mr. Xie received his M.Sc. degree in Computer Science from Western University in 2006 and Master of Business Administration degree at Richard Ivey School of Business in 2016.
Qixin Liu, M.Sc.
Qixin Liu, M.Sc.CTO and Co-founder
Mr. Liu has 20 years of experiences in network application, software architecture and computer system. He was formerly the Chief Technology Officer at Computer and Information Management Centre of Tsinghua University, where he was dedicated in building highly reliable and efficient online education systems. He was also the Chief Architect of GridSeed where his team delivered the first Bitcoin and Litecoin dual-mode mining device in the world.